LY3509754

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3509754, covering 2025-01-03 to 2025-01-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants [Phase 1]